Reference: 330_SS_RA

IDIBELL is looking for a position as Research Assistant for the Cancer Immunotherapy Lab.

About the research group

The Cancer Immunotherapy Group at the Catalan Institute of Oncology and Biomedical Research Institute of Bellvitge explores new anticancer treatments based on oncolytic adenoviruses and other immunotherapies. Within this context we are creating a new line of research based on modified NK cells for cellular immunotherapy

About the role

Develop a new line of research focused on the design of new CARs (chimeric antigen receptors) for the treatment of cancer. This development includes the in silico CAR design, generation of viral vectors, modification of effector cells and validation in in vitro and in vivo models.

Job requirements

Professional experience

• Previous experience in immunology and genetic engineering
• Experience with Tcells or NK cells
  

Education and training

•  Master degree in Biotechnology or similar

Technical skills 

• Experience in preclinical models of cancer and in vivo models
  
• Lentiviral and retroviral production

Languages

•  Good command of the English language

We will value, but not required

• Cytometry experience
  

What do we offer

• Nº of positions: 1
• Start date: 23 May 2022
• Contract duration: 
• Estimated annual gross salary: it is commensurate with qualifications and consistent with our pay ranges.
• You will be part of a multicultural team. We have a fun loving and friendly international work environment.
• Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.
• Benefits of constant training are offered.
• We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination.

Selection process

• Pre-selection: The pre-selection process will consist on an eligibility check based on qualifications and expertise reflected on the candidate's CV.
• Interview: Best positioned, pre-selected candidates may be called to arrange an interview. Candidates will be interviewed by the hiring manager and an ad hoc selection panel.
• Formal offer letter: Once identified, the People Management Unit will send a job offer to the successful candidate indicating start date, salary, working conditions, and any additional relevant details.

Deadline: Please submit your application by 10 May 2022 

Data protection notice

IDIBELL ensures that applicants’ personal data are processed as required by the EU General Data Protection Regulation (GDPR) and Spanish Law 3/2018 on Data Protection. Personal data is processed solely for the purpose of the selection procedure.

Our institute

IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.

Observations

The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).

IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).